As GLP-1s boom, dietician startups Berry Street, Fay each nab $50M rounds
5 February 2025 at 11:30
For decades, the U.S. healthcare system has struggled to address the diet-related chronic illnesses affecting nearly half of all adults. That changed in recent years with the discovery of Ozempic and other GLP-1 drugs that help people lose weight. While insurance covers these medications, doctors frequently require patients to see a nutritionist as part of [โฆ]
ยฉ 2024 TechCrunch. All rights reserved. For personal use only.